カテゴリー： Market Monitor Global, 世界, 医療/バイオ

リファブチンの世界市場見通し2023年-2029年

◆英語タイトル：Rifabutin Market, Global Outlook and Forecast 2023-2029
	◆商品コード：MMG23LY8639 ◆発行会社（リサーチ会社）：Market Monitor Global ◆発行日：2023年7月 ◆ページ数：63 ◆レポート形式：英語 / PDF ◆納品方法：Eメール（受注後2-3営業日） ◆調査対象地域：グローバル ◆産業分野：医薬品＆ヘルスケア

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,250 ⇒換算￥487,500	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD4,225 ⇒換算￥633,750	見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）	USD4,875 ⇒換算￥731,250	見積依頼/購入/質問フォーム

★Market Monitor Globalに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Global Rifabutin Market 調査レポートは次の情報を含め、グローバルにおけるのリファブチン市場規模と予測を収録しています。・世界のリファブチン市場：売上、2018年-2023年、2024年-2029年
・世界のリファブチン市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界のリファブチン市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。アメリカ市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「25mg」セグメントは今後6年間、000%の年平均成長率で2029年までに000Mドルに成長すると予測されています。

リファブチンのグローバル主要企業は、RedHill Biopharma Ltd.、 Pfizer、 Lupin、 Olon、 Janssen Pharma、 JINLAN Pharm-Drugs Technology Co., Ltd.、 NOVITIUM PHARMA、 Guangzhou Tosun Pharmaceutical、 Chongqing Huapont Pharmaceutical、 5M Biotech India、 SR Chemical And Pharmaceuticals、 LOK-BETA Pharmaceuticals (I) Pvt Ltd、 HANGZHOU HEXO CHEMTECH CO., LTDなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

マーケットモニターグローバル社は、リファブチンのメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別マーケット分析】

世界のリファブチン市場：タイプ別、2018年-2023年、2024年-2029年
世界のリファブチン市場：タイプ別市場シェア、2022年
・25mg、100mg、150mg

世界のリファブチン市場：用途別、2018年-2023年、2024年-2029年
世界のリファブチン市場：用途別市場シェア、2022年
・薬局、病院、診療所、その他

世界のリファブチン市場：地域・国別、2018年-2023年、2024年-2029年
世界のリファブチン市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競争分析】

また、当レポートは主要な参入企業の分析を提供します。
・主要企業におけるリファブチンのグローバル売上、2018年-2023年
・主要企業におけるリファブチンのグローバル売上シェア、2022年
・主要企業におけるリファブチンのグローバル販売量、2018年-2023年
・主要企業におけるリファブチンのグローバル販売量シェア、2022年

さらに、当レポートは主要企業の情報を提示します。
RedHill Biopharma Ltd.、 Pfizer、 Lupin、 Olon、 Janssen Pharma、 JINLAN Pharm-Drugs Technology Co., Ltd.、 NOVITIUM PHARMA、 Guangzhou Tosun Pharmaceutical、 Chongqing Huapont Pharmaceutical、 5M Biotech India、 SR Chemical And Pharmaceuticals、 LOK-BETA Pharmaceuticals (I) Pvt Ltd、 HANGZHOU HEXO CHEMTECH CO., LTD

*************************************************************

・調査・分析レポートの概要
リファブチン市場の定義
市場セグメント
世界のリファブチン市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界のリファブチン市場規模
世界のリファブチン市場規模：2022年 VS 2029年
世界のリファブチン市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでのリファブチンの売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業のリファブチン製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：25mg、100mg、150mg
リファブチンのタイプ別グローバル売上・予測

・用途別市場分析
用途区分：薬局、病院、診療所、その他
リファブチンの用途別グローバル売上・予測

・地域別市場分析
地域別リファブチン市場規模 2022年と2029年
地域別リファブチン売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業の情報（企業概要、事業概要、主要製品、売上、ニュースなど）
RedHill Biopharma Ltd.、 Pfizer、 Lupin、 Olon、 Janssen Pharma、 JINLAN Pharm-Drugs Technology Co., Ltd.、 NOVITIUM PHARMA、 Guangzhou Tosun Pharmaceutical、 Chongqing Huapont Pharmaceutical、 5M Biotech India、 SR Chemical And Pharmaceuticals、 LOK-BETA Pharmaceuticals (I) Pvt Ltd、 HANGZHOU HEXO CHEMTECH CO., LTD
...

This report aims to provide a comprehensive presentation of the global market for Rifabutin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Rifabutin. This report contains market size and forecasts of Rifabutin in global, including the following market information:
Global Rifabutin Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Rifabutin market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
25 mg Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Rifabutin include RedHill Biopharma Ltd., Pfizer, Lupin, Olon, Janssen Pharma, JINLAN Pharm-Drugs Technology Co., Ltd., NOVITIUM PHARMA, Guangzhou Tosun Pharmaceutical and Chongqing Huapont Pharmaceutical, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Rifabutin companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Rifabutin Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Rifabutin Market Segment Percentages, by Type, 2022 (%)
25 mg
100 mg
150 mg
Global Rifabutin Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Rifabutin Market Segment Percentages, by Application, 2022 (%)
Pharmacy
Hospital
Clinic
Others
Global Rifabutin Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Rifabutin Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Rifabutin revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Rifabutin revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
RedHill Biopharma Ltd.
Pfizer
Lupin
Olon
Janssen Pharma
JINLAN Pharm-Drugs Technology Co., Ltd.
NOVITIUM PHARMA
Guangzhou Tosun Pharmaceutical
Chongqing Huapont Pharmaceutical
5M Biotech India
SR Chemical And Pharmaceuticals
LOK-BETA Pharmaceuticals (I) Pvt Ltd
HANGZHOU HEXO CHEMTECH CO., LTD
Outline of Major Chapters:
Chapter 1: Introduces the definition of Rifabutin, market overview.
Chapter 2: Global Rifabutin market size in revenue.
Chapter 3: Detailed analysis of Rifabutin company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Rifabutin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Rifabutin Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Rifabutin Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Rifabutin Overall Market Size
2.1 Global Rifabutin Market Size: 2022 VS 2029
2.2 Global Rifabutin Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Rifabutin Players in Global Market
3.2 Top Global Rifabutin Companies Ranked by Revenue
3.3 Global Rifabutin Revenue by Companies
3.4 Top 3 and Top 5 Rifabutin Companies in Global Market, by Revenue in 2022
3.5 Global Companies Rifabutin Product Type
3.6 Tier 1, Tier 2 and Tier 3 Rifabutin Players in Global Market
3.6.1 List of Global Tier 1 Rifabutin Companies
3.6.2 List of Global Tier 2 and Tier 3 Rifabutin Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type – Global Rifabutin Market Size Markets, 2022 & 2029
4.1.2 25 mg
4.1.3 100 mg
4.1.4 150 mg
4.2 By Type – Global Rifabutin Revenue & Forecasts
4.2.1 By Type – Global Rifabutin Revenue, 2018-2023
4.2.2 By Type – Global Rifabutin Revenue, 2024-2029
4.2.3 By Type – Global Rifabutin Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Rifabutin Market Size, 2022 & 2029
5.1.2 Pharmacy
5.1.3 Hospital
5.1.4 Clinic
5.1.5 Others
5.2 By Application – Global Rifabutin Revenue & Forecasts
5.2.1 By Application – Global Rifabutin Revenue, 2018-2023
5.2.2 By Application – Global Rifabutin Revenue, 2024-2029
5.2.3 By Application – Global Rifabutin Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region – Global Rifabutin Market Size, 2022 & 2029
6.2 By Region – Global Rifabutin Revenue & Forecasts
6.2.1 By Region – Global Rifabutin Revenue, 2018-2023
6.2.2 By Region – Global Rifabutin Revenue, 2024-2029
6.2.3 By Region – Global Rifabutin Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country – North America Rifabutin Revenue, 2018-2029
6.3.2 US Rifabutin Market Size, 2018-2029
6.3.3 Canada Rifabutin Market Size, 2018-2029
6.3.4 Mexico Rifabutin Market Size, 2018-2029
6.4 Europe
6.4.1 By Country – Europe Rifabutin Revenue, 2018-2029
6.4.2 Germany Rifabutin Market Size, 2018-2029
6.4.3 France Rifabutin Market Size, 2018-2029
6.4.4 U.K. Rifabutin Market Size, 2018-2029
6.4.5 Italy Rifabutin Market Size, 2018-2029
6.4.6 Russia Rifabutin Market Size, 2018-2029
6.4.7 Nordic Countries Rifabutin Market Size, 2018-2029
6.4.8 Benelux Rifabutin Market Size, 2018-2029
6.5 Asia
6.5.1 By Region – Asia Rifabutin Revenue, 2018-2029
6.5.2 China Rifabutin Market Size, 2018-2029
6.5.3 Japan Rifabutin Market Size, 2018-2029
6.5.4 South Korea Rifabutin Market Size, 2018-2029
6.5.5 Southeast Asia Rifabutin Market Size, 2018-2029
6.5.6 India Rifabutin Market Size, 2018-2029
6.6 South America
6.6.1 By Country – South America Rifabutin Revenue, 2018-2029
6.6.2 Brazil Rifabutin Market Size, 2018-2029
6.6.3 Argentina Rifabutin Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country – Middle East & Africa Rifabutin Revenue, 2018-2029
6.7.2 Turkey Rifabutin Market Size, 2018-2029
6.7.3 Israel Rifabutin Market Size, 2018-2029
6.7.4 Saudi Arabia Rifabutin Market Size, 2018-2029
6.7.5 UAE Rifabutin Market Size, 2018-2029
7 Rifabutin Companies Profiles
7.1 RedHill Biopharma Ltd.
7.1.1 RedHill Biopharma Ltd. Company Summary
7.1.2 RedHill Biopharma Ltd. Business Overview
7.1.3 RedHill Biopharma Ltd. Rifabutin Major Product Offerings
7.1.4 RedHill Biopharma Ltd. Rifabutin Revenue in Global Market (2018-2023)
7.1.5 RedHill Biopharma Ltd. Key News & Latest Developments
7.2 Pfizer
7.2.1 Pfizer Company Summary
7.2.2 Pfizer Business Overview
7.2.3 Pfizer Rifabutin Major Product Offerings
7.2.4 Pfizer Rifabutin Revenue in Global Market (2018-2023)
7.2.5 Pfizer Key News & Latest Developments
7.3 Lupin
7.3.1 Lupin Company Summary
7.3.2 Lupin Business Overview
7.3.3 Lupin Rifabutin Major Product Offerings
7.3.4 Lupin Rifabutin Revenue in Global Market (2018-2023)
7.3.5 Lupin Key News & Latest Developments
7.4 Olon
7.4.1 Olon Company Summary
7.4.2 Olon Business Overview
7.4.3 Olon Rifabutin Major Product Offerings
7.4.4 Olon Rifabutin Revenue in Global Market (2018-2023)
7.4.5 Olon Key News & Latest Developments
7.5 Janssen Pharma
7.5.1 Janssen Pharma Company Summary
7.5.2 Janssen Pharma Business Overview
7.5.3 Janssen Pharma Rifabutin Major Product Offerings
7.5.4 Janssen Pharma Rifabutin Revenue in Global Market (2018-2023)
7.5.5 Janssen Pharma Key News & Latest Developments
7.6 JINLAN Pharm-Drugs Technology Co., Ltd.
7.6.1 JINLAN Pharm-Drugs Technology Co., Ltd. Company Summary
7.6.2 JINLAN Pharm-Drugs Technology Co., Ltd. Business Overview
7.6.3 JINLAN Pharm-Drugs Technology Co., Ltd. Rifabutin Major Product Offerings
7.6.4 JINLAN Pharm-Drugs Technology Co., Ltd. Rifabutin Revenue in Global Market (2018-2023)
7.6.5 JINLAN Pharm-Drugs Technology Co., Ltd. Key News & Latest Developments
7.7 NOVITIUM PHARMA
7.7.1 NOVITIUM PHARMA Company Summary
7.7.2 NOVITIUM PHARMA Business Overview
7.7.3 NOVITIUM PHARMA Rifabutin Major Product Offerings
7.7.4 NOVITIUM PHARMA Rifabutin Revenue in Global Market (2018-2023)
7.7.5 NOVITIUM PHARMA Key News & Latest Developments
7.8 Guangzhou Tosun Pharmaceutical
7.8.1 Guangzhou Tosun Pharmaceutical Company Summary
7.8.2 Guangzhou Tosun Pharmaceutical Business Overview
7.8.3 Guangzhou Tosun Pharmaceutical Rifabutin Major Product Offerings
7.8.4 Guangzhou Tosun Pharmaceutical Rifabutin Revenue in Global Market (2018-2023)
7.8.5 Guangzhou Tosun Pharmaceutical Key News & Latest Developments
7.9 Chongqing Huapont Pharmaceutical
7.9.1 Chongqing Huapont Pharmaceutical Company Summary
7.9.2 Chongqing Huapont Pharmaceutical Business Overview
7.9.3 Chongqing Huapont Pharmaceutical Rifabutin Major Product Offerings
7.9.4 Chongqing Huapont Pharmaceutical Rifabutin Revenue in Global Market (2018-2023)
7.9.5 Chongqing Huapont Pharmaceutical Key News & Latest Developments
7.10 5M Biotech India
7.10.1 5M Biotech India Company Summary
7.10.2 5M Biotech India Business Overview
7.10.3 5M Biotech India Rifabutin Major Product Offerings
7.10.4 5M Biotech India Rifabutin Revenue in Global Market (2018-2023)
7.10.5 5M Biotech India Key News & Latest Developments
7.11 SR Chemical And Pharmaceuticals
7.11.1 SR Chemical And Pharmaceuticals Company Summary
7.11.2 SR Chemical And Pharmaceuticals Business Overview
7.11.3 SR Chemical And Pharmaceuticals Rifabutin Major Product Offerings
7.11.4 SR Chemical And Pharmaceuticals Rifabutin Revenue in Global Market (2018-2023)
7.11.5 SR Chemical And Pharmaceuticals Key News & Latest Developments
7.12 LOK-BETA Pharmaceuticals (I) Pvt Ltd
7.12.1 LOK-BETA Pharmaceuticals (I) Pvt Ltd Company Summary
7.12.2 LOK-BETA Pharmaceuticals (I) Pvt Ltd Business Overview
7.12.3 LOK-BETA Pharmaceuticals (I) Pvt Ltd Rifabutin Major Product Offerings
7.12.4 LOK-BETA Pharmaceuticals (I) Pvt Ltd Rifabutin Revenue in Global Market (2018-2023)
7.12.5 LOK-BETA Pharmaceuticals (I) Pvt Ltd Key News & Latest Developments
7.13 HANGZHOU HEXO CHEMTECH CO., LTD
7.13.1 HANGZHOU HEXO CHEMTECH CO., LTD Company Summary
7.13.2 HANGZHOU HEXO CHEMTECH CO., LTD Business Overview
7.13.3 HANGZHOU HEXO CHEMTECH CO., LTD Rifabutin Major Product Offerings
7.13.4 HANGZHOU HEXO CHEMTECH CO., LTD Rifabutin Revenue in Global Market (2018-2023)
7.13.5 HANGZHOU HEXO CHEMTECH CO., LTD Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List of Tables
Table 1. Rifabutin Market Opportunities & Trends in Global Market
Table 2. Rifabutin Market Drivers in Global Market
Table 3. Rifabutin Market Restraints in Global Market
Table 4. Key Players of Rifabutin in Global Market
Table 5. Top Rifabutin Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Rifabutin Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Rifabutin Revenue Share by Companies, 2018-2023
Table 8. Global Companies Rifabutin Product Type
Table 9. List of Global Tier 1 Rifabutin Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Rifabutin Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Rifabutin Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Rifabutin Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Rifabutin Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application – Global Rifabutin Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Rifabutin Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Rifabutin Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region – Global Rifabutin Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Rifabutin Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Rifabutin Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Rifabutin Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Rifabutin Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Rifabutin Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Rifabutin Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Rifabutin Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Rifabutin Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Rifabutin Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Rifabutin Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Rifabutin Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Rifabutin Revenue, (US$, Mn), 2024-2029
Table 30. RedHill Biopharma Ltd. Company Summary
Table 31. RedHill Biopharma Ltd. Rifabutin Product Offerings
Table 32. RedHill Biopharma Ltd. Rifabutin Revenue (US$, Mn) & (2018-2023)
Table 33. RedHill Biopharma Ltd. Key News & Latest Developments
Table 34. Pfizer Company Summary
Table 35. Pfizer Rifabutin Product Offerings
Table 36. Pfizer Rifabutin Revenue (US$, Mn) & (2018-2023)
Table 37. Pfizer Key News & Latest Developments
Table 38. Lupin Company Summary
Table 39. Lupin Rifabutin Product Offerings
Table 40. Lupin Rifabutin Revenue (US$, Mn) & (2018-2023)
Table 41. Lupin Key News & Latest Developments
Table 42. Olon Company Summary
Table 43. Olon Rifabutin Product Offerings
Table 44. Olon Rifabutin Revenue (US$, Mn) & (2018-2023)
Table 45. Olon Key News & Latest Developments
Table 46. Janssen Pharma Company Summary
Table 47. Janssen Pharma Rifabutin Product Offerings
Table 48. Janssen Pharma Rifabutin Revenue (US$, Mn) & (2018-2023)
Table 49. Janssen Pharma Key News & Latest Developments
Table 50. JINLAN Pharm-Drugs Technology Co., Ltd. Company Summary
Table 51. JINLAN Pharm-Drugs Technology Co., Ltd. Rifabutin Product Offerings
Table 52. JINLAN Pharm-Drugs Technology Co., Ltd. Rifabutin Revenue (US$, Mn) & (2018-2023)
Table 53. JINLAN Pharm-Drugs Technology Co., Ltd. Key News & Latest Developments
Table 54. NOVITIUM PHARMA Company Summary
Table 55. NOVITIUM PHARMA Rifabutin Product Offerings
Table 56. NOVITIUM PHARMA Rifabutin Revenue (US$, Mn) & (2018-2023)
Table 57. NOVITIUM PHARMA Key News & Latest Developments
Table 58. Guangzhou Tosun Pharmaceutical Company Summary
Table 59. Guangzhou Tosun Pharmaceutical Rifabutin Product Offerings
Table 60. Guangzhou Tosun Pharmaceutical Rifabutin Revenue (US$, Mn) & (2018-2023)
Table 61. Guangzhou Tosun Pharmaceutical Key News & Latest Developments
Table 62. Chongqing Huapont Pharmaceutical Company Summary
Table 63. Chongqing Huapont Pharmaceutical Rifabutin Product Offerings
Table 64. Chongqing Huapont Pharmaceutical Rifabutin Revenue (US$, Mn) & (2018-2023)
Table 65. Chongqing Huapont Pharmaceutical Key News & Latest Developments
Table 66. 5M Biotech India Company Summary
Table 67. 5M Biotech India Rifabutin Product Offerings
Table 68. 5M Biotech India Rifabutin Revenue (US$, Mn) & (2018-2023)
Table 69. 5M Biotech India Key News & Latest Developments
Table 70. SR Chemical And Pharmaceuticals Company Summary
Table 71. SR Chemical And Pharmaceuticals Rifabutin Product Offerings
Table 72. SR Chemical And Pharmaceuticals Rifabutin Revenue (US$, Mn) & (2018-2023)
Table 73. SR Chemical And Pharmaceuticals Key News & Latest Developments
Table 74. LOK-BETA Pharmaceuticals (I) Pvt Ltd Company Summary
Table 75. LOK-BETA Pharmaceuticals (I) Pvt Ltd Rifabutin Product Offerings
Table 76. LOK-BETA Pharmaceuticals (I) Pvt Ltd Rifabutin Revenue (US$, Mn) & (2018-2023)
Table 77. LOK-BETA Pharmaceuticals (I) Pvt Ltd Key News & Latest Developments
Table 78. HANGZHOU HEXO CHEMTECH CO., LTD Company Summary
Table 79. HANGZHOU HEXO CHEMTECH CO., LTD Rifabutin Product Offerings
Table 80. HANGZHOU HEXO CHEMTECH CO., LTD Rifabutin Revenue (US$, Mn) & (2018-2023)
Table 81. HANGZHOU HEXO CHEMTECH CO., LTD Key News & Latest Developments
List of Figures
Figure 1. Rifabutin Segment by Type in 2022
Figure 2. Rifabutin Segment by Application in 2022
Figure 3. Global Rifabutin Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Rifabutin Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Rifabutin Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Rifabutin Revenue in 2022
Figure 8. By Type - Global Rifabutin Revenue Market Share, 2018-2029
Figure 9. By Application - Global Rifabutin Revenue Market Share, 2018-2029
Figure 10. By Type - Global Rifabutin Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Rifabutin Revenue Market Share, 2018-2029
Figure 12. By Application - Global Rifabutin Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Rifabutin Revenue Market Share, 2018-2029
Figure 14. By Region - Global Rifabutin Revenue Market Share, 2018-2029
Figure 15. By Country - North America Rifabutin Revenue Market Share, 2018-2029
Figure 16. US Rifabutin Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Rifabutin Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Rifabutin Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Rifabutin Revenue Market Share, 2018-2029
Figure 20. Germany Rifabutin Revenue, (US$, Mn), 2018-2029
Figure 21. France Rifabutin Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Rifabutin Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Rifabutin Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Rifabutin Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Rifabutin Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Rifabutin Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Rifabutin Revenue Market Share, 2018-2029
Figure 28. China Rifabutin Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Rifabutin Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Rifabutin Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Rifabutin Revenue, (US$, Mn), 2018-2029
Figure 32. India Rifabutin Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Rifabutin Revenue Market Share, 2018-2029
Figure 34. Brazil Rifabutin Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Rifabutin Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Rifabutin Revenue Market Share, 2018-2029
Figure 37. Turkey Rifabutin Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Rifabutin Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Rifabutin Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Rifabutin Revenue, (US$, Mn), 2018-2029
Figure 41. RedHill Biopharma Ltd. Rifabutin Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Pfizer Rifabutin Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Lupin Rifabutin Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Olon Rifabutin Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Janssen Pharma Rifabutin Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. JINLAN Pharm-Drugs Technology Co., Ltd. Rifabutin Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. NOVITIUM PHARMA Rifabutin Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Guangzhou Tosun Pharmaceutical Rifabutin Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Chongqing Huapont Pharmaceutical Rifabutin Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. 5M Biotech India Rifabutin Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. SR Chemical And Pharmaceuticals Rifabutin Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. LOK-BETA Pharmaceuticals (I) Pvt Ltd Rifabutin Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. HANGZHOU HEXO CHEMTECH CO., LTD Rifabutin Revenue Year Over Year Growth (US$, Mn) & (2018-2023)

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ リファブチンの世界市場見通し2023年-2029年(Rifabutin Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

リファブチンの世界市場見通し2023年-2029年

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp